B. Therrell

发表

Current status of newborn screening worldwide: 2015.

J. Loeber, B. Therrell, C. Padilla, 2015, Seminars in perinatology.

Long-term follow-up after diagnosis resulting from newborn screening: Statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children

A. Kemper, J. Figge, A. Hinman, 2008, Genetics in Medicine.

Barriers to implementing sustainable national newborn screening in developing health systems

B. Therrell, C. Padilla, 2014 .

Newborn screening for hyperargininemia due to arginase 1 deficiency.

S. Cederbaum, B. Therrell, R. Currier, 2017, Molecular genetics and metabolism.

What's new in newborn screening?

B. Therrell, M. Lloyd-Puryear, M. Mann, 2008 .

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

S. Rivkees, D. Poppas, P. White, 2010, International journal of pediatric endocrinology.

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder

E. C. Neto, T. Kizaki, M. Mitchell, 1993 .

Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia

S. Berenbaum, B. Therrell, L. Prentice, 1998, Pediatrics.

Newborn screening for congenital adrenal hyperplasia.

B. Therrell, 2001, Endocrinology and metabolism clinics of North America.

Newborn screening in the developing countries

B. Therrell, C. Padilla, 2018, Current opinion in pediatrics.

Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services.

Michael R. Glass, E. McCabe, W. H. Hannon, 1996, Biochemical and molecular medicine.

Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).

W. H. Hannon, B. Therrell, M. Mann, 2010, Seminars in perinatology.

Standardizing newborn screening results for health information exchange.

S. Abhyankar, C. McDonald, G. Downing, 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

U.S. newborn screening policy dilemmas for the twenty-first century.

B. Therrell, 2001, Molecular genetics and metabolism.

Newborn Screening Policy Dilemmas for the Twenty-First Century

B. Therrell, 2001 .

U.S. newborn screening system guidelines: Statement of the council of regional networks for genetic services

E. McCabe, W. H. Hannon, A. Davidson, 1992 .

Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss

K. Arnos, A. Pandya, M. Watson, 2002, Genetics in Medicine.

Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments.

B. Therrell, Colleen Buechner, 2008, Annals of the Academy of Medicine, Singapore.

Newborn Screening for Congenital Hypothyroidism in India: Let's Just Do It!

B. Therrell, 2019, Indian pediatrics.

Editorial

Piyush Gupta, B. Therrell, S. Dutta, 2019, Indian Pediatrics.

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning.

Kathryn M. Camp, B. Therrell, M. Lloyd-Puryear, 2014, Molecular genetics and metabolism.

Neuroblastoma screening in the united states

L. Foxhall, J. Ater, B. Therrell, 1998, Cancer.

Overview of the History and Applications of Dried Blood Samples

W. H. Hannon, B. Therrell, 2014 .

Universal newborn screening: A roadmap for action.

X. Zhao, E. McCabe, R. Giugliani, 2018, Molecular genetics and metabolism.

Newborn screening progress in developing countries--overcoming internal barriers.

B. Therrell, C. Padilla, D. Krotoski, 2010, Seminars in perinatology.

Communication of positive newborn screening results for sickle cell disease and sickle cell trait: Variation across states

C. J. Wang, H. Bauchner, P. Kavanagh, 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

Minireview Newborn screening: rationale for a comprehensive, fully integrated public health system

E. McCabe, L. Mccabe, B. Therrell, 2002 .

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

S. Terry, B. No̸rgaard-Pedersen, D. Bailey, 2011, Genetics in Medicine.

Experiences with sickle hemoglobin testing in the Texas Newborn Screening Program.

B. Therrell, M. Wilborn, J. Simmank, 1989, Pediatrics.

Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry

D. Millington, B. Therrell, C. Padilla, 2022, International journal of neonatal screening.

Considerations in choosing screening conditions: one (US) approach.

B. Therrell, 2008, Annals of the Academy of Medicine, Singapore.

Understanding newborn screening system issues with emphasis on cystic fibrosis screening.

B. Therrell, M. Lloyd-Puryear, M. Mann, 2005, The Journal of pediatrics.

Challenges and opportunities in establishing and maintaining newborn screening systems.

B. Therrell, 2003, The Southeast Asian journal of tropical medicine and public health.

Newborn screening: the role of the obstetrician.

A. Larsson, B. Therrell, 2002, Clinical obstetrics and gynecology.

Including ELSI research questions in newborn screening pilot studies

T. Crawford, B. Wilfond, A. Clarke, 2018, Genetics in Medicine.

Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents

H. Northrup, B. Therrell, S. Noblin, 2009, Genetics in Medicine.

Long-term follow-up data collection and use in state newborn screening programs.

Timothy Hoff, T. Hoff, B. Therrell, 2007, Archives of pediatrics & adolescent medicine.

Tracking clinical genetic services for newborns identified through newborn dried bloodspot screening in the United States—lessons learned

C. Kaye, D. Grange, B. Therrell, 2011, Journal of Community Genetics.

Exploring barriers to long-term follow-up in newborn screening programs

T. Hoff, Adrienne T Hoyt, B. Therrell, 2006, Genetics in Medicine.

Consolidating newborn screening efforts in the Asia Pacific region

B. Therrell, C. Padilla, on behalf of the Working Group of the Asia Pacific So Region, 2012, Journal of Community Genetics.

Successful Implementation of Newborn Screening for Hemoglobin Disorders in the Philippines

B. Therrell, C. Padilla, C. Hoppe, 2021, International journal of neonatal screening.

Using LOINC and HL 7 to Standardize Hemoglobinopathy Screening Result Reporting

S. Abhyankar, C. McDonald, R. Eaton, 2011 .

Newborn Screening Health Information Exchange: Updated Guidance for Coding and HL7 Electronic Messaging

S. Abhyankar, A. Zuckerman, R. Goodwin, 2011 .

Financing newborn screening: sources, issues, and future considerations.

L. R. Ramos, B. Therrell, M. Lloyd-Puryear, 2007, Journal of public health management and practice : JPHMP.

Newborn screening as we move to the twenty-first century.

B. Therrell, 1999, The Southeast Asian journal of tropical medicine and public health.

Status of Newborn Screening Programs in the United States

B. Therrell, Donna Williams, Alissa Johnson, 2006, Pediatrics.

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

M. Watson, A. Barkat, T. Mvalo, 2020, Journal of Community Genetics.

Newborn screening in the Asia Pacific region

B. Therrell, C. Padilla, 2007, Journal of Inherited Metabolic Disease.

History and current status of newborn screening for hemoglobinopathies.

B. Therrell, J. Benson, 2010, Seminars in perinatology.

Trends in Incidence Rates of Congenital Hypothyroidism Related to Select Demographic Factors: Data From the United States, California, Massachusetts, New York, and Texas

R. Eaton, B. Therrell, F. Lorey, 2010, Pediatrics.

Empowering newborn screening programs in African countries through establishment of an international collaborative effort

M. Watson, A. Barkat, T. Mvalo, 2020, Journal of Community Genetics.

Effect of Laboratory Practices on the Incidence Rate of Congenital Hypothyroidism

V. Hertzberg, B. Therrell, J. Mei, 2010, Pediatrics.

Integrating Genetic Services into Public Health – Guidance for State and Territorial Programs from the National Newborn Screening and Genetics Resource Center (NNSGRC)

E. McCabe, R. Laxová, C. Kaye, 2002, Public Health Genomics.

Impact of expanded newborn screening--United States, 2006.

O. Devine, D. Frazier, C. Boyle, 2008, MMWR. Morbidity and mortality weekly report.

DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up.

E. McCabe, U. Bhardwaj, L. Mccabe, 2003, The Journal of pediatrics.

Newborn screening in North America

B. Therrell, John Adams, 2007, Journal of Inherited Metabolic Disease.

. Screening Newborns in the Asia-Pacific Region

B. Therrell, C. Padilla, 2012 .

Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement

Lita L. Orbillo, B. Therrell, C. Padilla, 2020, International journal of neonatal screening.

Second testing for hypothyroidism.

B. Therrell, G. Levine, 1986, Pediatrics.

A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.

J. Annegers, P. Brosnan, B. Therrell, 1998, Public health reports.

Newborn screening: rationale for a comprehensive, fully integrated public health system.

E. McCabe, L. Mccabe, B. Therrell, 2002, Molecular genetics and metabolism.

Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades.

J. Eckman, B. Therrell, M. Lloyd-Puryear, 2015, Seminars in perinatology.

Newborn Screening Long-Term Follow-Up Clinics (Continuity Clinics) in the Philippines during the COVID-19 Pandemic: Continuing Quality Patient Care

B. Therrell, C. Padilla, Michelle E. Abadingo, 2022, International journal of neonatal screening.

A framework for assessing outcomes from newborn screening: on the road to measuring its promise.

A. Zuckerman, D. Dougherty, C. Kaye, 2016, Molecular genetics and metabolism.

Parental Permission for Pilot Newborn Screening Research: Guidelines From the NBSTRN

B. Wilfond, M. Watson, J. Botkin, 2014, Pediatrics.

Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States.

V. Hertzberg, B. Therrell, S. K. Shapira, 2011, The Journal of pediatrics.

National evaluation of US newborn screening system components.

W. H. Hannon, B. Therrell, 2006, Mental retardation and developmental disabilities research reviews.

An Effective Program to Resolve Ambiguous Results from State Newborn Hemoglobinopathy Screening.

E. Vichinsky, B. Lubin, B. Therrell, 2004 .

Financing State Newborn Screening Programs: Sources and Uses of Funds

L. R. Ramos, B. Therrell, M. Lloyd-Puryear, 2006, Pediatrics.

Design and Evaluation of a Decision Aid for Inviting Parents to Participate in a Fragile X Newborn Screening Pilot Study

D. Bailey, C. Powell, Megan A. Lewis, 2013, Journal of Genetic Counseling.

Naming and Counting Disorders (Conditions) Included in Newborn Screening Panels

W Harry Hannon, Michael S Watson, M. Watson, 2006, Pediatrics.

Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: challenges in newborn dried blood spot screening.

P. Farrell, W. H. Hannon, B. Therrell, 2012, Molecular genetics and metabolism.

Effect of lot-to-lot variability in filter paper on the quantification of thyroxin, thyrotropin, and phenylalanine in dried-blood specimens.

D. Phillips, W. H. Hannon, B. Therrell, 1988, Clinical chemistry.

Including ELSI research questions in newborn screening pilot studies

Bruce E. Bowdish, T. Crawford, B. Wilfond, 2018, Genetics in Medicine.

Preliminary investigation of the use of dried-blood spots for the assessment of in utero exposure to environmental pollutants.

W. H. Hannon, B. Therrell, V. Burse, 1997, Biochemical and molecular medicine.

Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary

Michael S. Watson, Piero Rinaldo, B. Yawn, 2006, Pediatrics.

Edinburgh Research Explorer Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative

S. Rivkees, D. Poppas, P. White, 2022 .

Genotypic Confirmation from the Original Dried Blood Specimens in a Neonatal Hemoglobinopathy Screening Program

E. McCabe, L. Mccabe, B. Therrell, 1992, Pediatric Research.

Consolidating newborn screening efforts in the Asia Pacific region

B. Therrell, C. Padilla, on behalf of the Working Group of the Asia Pacific So Region, 2012, Journal of Community Genetics.

Using tandem mass spectrometry for metabolic disease screening among newborns. A report of a work group.

J. Koplan, W. H. Hannon, E. Sampson, 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)

B. Therrell, G. Borrajo, I. Khneisser, 2024, International Journal of Neonatal Screening.

Overcoming challenges in sustaining newborn screening in low-middle-income countries: the Philippine newborn screening system

B. Therrell, Michelle E. Abadingo, Carmencita D. Padilla, 2023, Rare Disease and Orphan Drugs Journal.

Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors

M. Caggana, A. Comeau, B. Therrell, 2022, International Journal of Neonatal Screening.

Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services’ Advisory Committee on Heritable Disorders in Newborns and Children

Bradford L. Therrell, B. Therrell, Colleen Wu, 2012, Genetics in Medicine.